Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Neuroblastoma × Propranolol × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Hemangioma 6 Hemangioma, Capillary 3 Multiple Myeloma 2 Fallopian Tube Neoplasms 2 Breast Neoplasms 2 Tuberous Sclerosis 1 Prostatic Neoplasms 1 Neuroblastoma 1 Melanoma 1 Hemangiosarcoma 1 Hemangioma, Cavernous, Central Nervous System 1 Carcinoma, Ovarian Epithelial 1 Carcinoma, Hepatocellular 1 Breast Neoplasms, Male 1

Interventions

Cyclophosphamide 45 Etoposide 31 Filgrastim 27 Carboplatin 25 Doxorubicin 24 Vincristine 22 Melphalan 22 Isotretinoin 22 Topotecan 21 Granulocyte Colony-Stimulating Factor 19 Irinotecan 18 Peripheral Blood Stem Cell Transplantation 17 Cisplatin 16 sargramostim 15 Temozolomide 15 3-Iodobenzylguanidine 13 humanized 3F8 anti-GD2 monoclonal antibody 12 Radiotherapy 11 Granulocyte-Macrophage Colony-Stimulating Factor 10 dinutuximab 8 Busulfan 8 Interleukin-2 7 etoposide phosphate 6 aldesleukin 6 Stem Cell Transplantation 6 Polymerase Chain Reaction 6 Vorinostat 5 Thiotepa 5 Methylprednisolone 5 Ifosfamide 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02641314 2024-05-10

METRO-NB2012

University of Cologne

Phase 2 Completed

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡